SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-019129
Filing Date
2023-04-19
Accepted
2023-04-19 16:02:29
Documents
4
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 DEF14A ny20006965x1_def14a.htm DEF 14A 1072762
2 ny20006965x1_arrow.jpg GRAPHIC 8636
3 ny20006965x1_pc-1x1.jpg GRAPHIC 606315
4 ny20006965x1_pc-2x1.jpg GRAPHIC 519235
  Complete submission text file 0001140361-23-019129.txt   2635226
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36500 | Film No.: 23830050
SIC: 2834 Pharmaceutical Preparations